- Friday, April 28, 2023
12:00 PM – 1:00 PM CST
Elevate Care in Advanced Prostate Cancer | Sponsored by: Astellas Pharma and Pfizer Oncology
12:00 PM – 1:00 PM CST
Elevate Care in Advanced Prostate Cancer | Sponsored by: Astellas Pharma and Pfizer OncologyLocation: Product Theater in The S&T Hall, Booth #1260
David Scott Morris, MD,FACS (he/him/his) ### 718663###Speaker#########Speaker:
### he/him/his12:30 PM – 1:30 PM CST
An adaptable approach: Is JELMYTO appropriate acrosslow-grade UTUC presentations and practice patterns? | Sponsored by: UroGen® Pharma
12:30 PM – 1:30 PM CST
An adaptable approach: Is JELMYTO appropriate acrosslow-grade UTUC presentations and practice patterns? | Sponsored by: UroGen® PharmaLocation: Product Theater in The SquareSpeaker: – Providence Saint John’s Health Center
Speaker:
Jennifer Anne Linehan, MD – Providence Saint John’s Health Center ### 1407325###Speaker###Associate Professor of Urology and Urologic Oncology###Providence Saint John’s Health Center###Speaker: – Providence Saint John’s Health Center
### @@@ Sandip M. Prasad, MD, MPhil ### 1961873###Speaker#########Speaker:
### 2:30 PM – 3:30 PM CST
Radioligand Therapy: Open Clinical Trials in Prostate Cancer and Logistics of Administration | Sponsored by: Novartis
2:30 PM – 3:30 PM CST
Radioligand Therapy: Open Clinical Trials in Prostate Cancer and Logistics of Administration | Sponsored by: NovartisLocation: Product Theater in The S&T Hall Booth 1260
Jared Driskill, Pharm.D ### 1930625###Speaker#########Speaker:
### @@@ Dao Le, Pharm.D ### 1930624###Speaker#########Speaker:
### - Saturday, April 29, 2023
7:00 AM – 8:00 AM CST
A Treatment Option for Select Genitourinary Cancers and Adverse Reactions Management | Sponsored by: Merck & Co., Inc.
7:00 AM – 8:00 AM CST
A Treatment Option for Select Genitourinary Cancers and Adverse Reactions Management | Sponsored by: Merck & Co., Inc.Location: Product Theater in The Square
Daniel Canter ### 1928761###Speaker#########Speaker:
### 9:30 AM – 10:30 AM CST
ERLEADA® (apalutamide)—For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) | Sponsored By: Janssen
9:30 AM – 10:30 AM CST
ERLEADA® (apalutamide)—For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) | Sponsored By: JanssenLocation: Product Theater in The S&T Hall, Booth #1260Speaker:
Speaker: – Ucla Medical School
Speaker:
Christopher Pieczonka, MD ### 388148###Speaker#########Speaker:
### @@@ Robert Evan Reiter, MD – Ucla Medical School ### 311326###Speaker######Ucla Medical School###Speaker: – Ucla Medical School
### @@@ Aaron Berger, MD ### 1961879###Speaker#########Speaker:
### 12:00 PM – 1:00 PM CST
Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer | Sponsored by: Astellas Pharma and Pfizer Oncology
12:00 PM – 1:00 PM CST
Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer | Sponsored by: Astellas Pharma and Pfizer OncologyLocation: Product Theater in The S&T Hall, Booth #1260
Kenneth M Kernen ### 1929251###Speaker#########Speaker:
### 12:30 PM – 1:30 PM CST
Incorporating Checkpoint Inhibition in the Treatment Landscape for Patients with Pathologically High-risk Urothelial Carcinoma | Sponsored by: Bristol Myers Squibb
12:30 PM – 1:30 PM CST
Incorporating Checkpoint Inhibition in the Treatment Landscape for Patients with Pathologically High-risk Urothelial Carcinoma | Sponsored by: Bristol Myers SquibbLocation: Product Theater in The Square
Gautam T. Jayram, MD ### 1777458###Speaker#########Speaker:
### 2:30 PM – 3:30 PM CST
Choices That Matter: Optimizing BPH Care for Urologists, APPs and Patients | Sponsored by: Teleflex Interventional Urology
2:30 PM – 3:30 PM CST
Choices That Matter: Optimizing BPH Care for Urologists, APPs and Patients | Sponsored by: Teleflex Interventional UrologyLocation: Product Theater in The S&T Hall Booth 1260Moderator:
Speaker:
Speaker: – UT Southwestern Medical Center
Matt Ashley, MD ### 1930575###Moderator#########Moderator:
### @@@ Janelle Bunce ### 1930589###Speaker#########Speaker:
### @@@ Claus Georg Roehrborn, MD (he/him/his) – UT Southwestern Medical Center ### 205158###Speaker###Department Chair###UT Southwestern Medical Center###Speaker: – UT Southwestern Medical Center
### he/him/his- Sunday, April 30, 2023
9:30 AM – 10:30 AM CST
PSMA PET in Prostate Cancer: A Case-based Discussion | Sponsored by: Lantheus
9:30 AM – 10:30 AM CST
PSMA PET in Prostate Cancer: A Case-based Discussion | Sponsored by: LantheusLocation: Product Theater in The S&T Hall Booth 1260Moderator:
Speaker: – Massachusetts General Hosptial
Speaker: – Thomas Jefferson University
Speaker:
Speaker: – Tulane University Medical School
Phillip Koo, MD ### 958956###Moderator#########Moderator:
### @@@ Jason Efstathiou, MD, PHD – Massachusetts General Hosptial ### 214559###Speaker###Professor###Massachusetts General Hosptial###Speaker: – Massachusetts General Hosptial
### @@@ Leonard G. Gomella, MD – Thomas Jefferson University ### 187775###Speaker###Professor And Chair, Thomas Jefferson University###Thomas Jefferson University###Speaker: – Thomas Jefferson University
### @@@ Michael A. Gorin, MD ### 668200###Speaker###Staff Urologist, Urology Associates & UPMC Western Maryland######Speaker:
### @@@ A. Oliver Sartor, MD – Tulane University Medical School ### 205170###Speaker######Tulane University Medical School###Speaker: – Tulane University Medical School
### 12:00 PM – 1:00 PM CST
Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment | Sponsored by: Urovant Pharma
12:00 PM – 1:00 PM CST
Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment | Sponsored by: Urovant PharmaLocation: Product Theater in The S&T Hall, Booth #1260
Nathaniel Barnes, MD ### 1961877###Speaker#########Speaker:
### @@@ Ashley H. Tapscott, DO ### 662824###Speaker#########Speaker:
### 12:30 PM – 1:30 PM CST
Case-based Learnings on a Treatment Approach for Certain Patients With High-Risk NMIBC
12:30 PM – 1:30 PM CST
Case-based Learnings on a Treatment Approach for Certain Patients With High-Risk NMIBC | Sponsored by: Merck & Co., Inc.Location: Product Theater in The Square
Kenneth M Kernen ### 1929251###Speaker#########Speaker:
###
